Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City

Objective. To describe the immunogenicity and safety of a tetravalent dengue vaccine (TAK-003) in healthy adolescents living in Mexico City, an area considered non-endemic for dengue (NCT03341637). Methods. Participants aged 12–17 years were randomized 3:1 to receive two doses (Month 0 and Month 3)...

Full description

Bibliographic Details
Main Authors: Shibadas Biswal, Jorge Fernando Mendez Galvan, Mercedes Macias Parra, Juan-Francisco Galan-Herrera, Monica Belisa Carrascal Rodriguez, Esteban Patricio Rodriguez Bueno, Manja Brose, Martina Rauscher, Inge LeFevre, Derek Wallace, Astrid Borkowski
Format: Article
Language:English
Published: Pan American Health Organization 2021-06-01
Series:Revista Panamericana de Salud Pública
Subjects:
vaccines
adolescents
immunogenicity
safety
dengue
mexico
Online Access:https://iris.paho.org/handle/10665.2/54151

Internet

https://iris.paho.org/handle/10665.2/54151

Similar Items